Stock listing

PAB Stock Price, News, Filings & Events — Patrys Limited

Selected listing: PAB · ASX · AUD · AU

This page tracks Patrys Limited's PAB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PAB:ASX. PAB:ASX is the stock-level entry point for investors researching Patrys Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Patrys Limited (Ticker: PAB) is a public company based in Australia with a market capitalization of approximately AUD 17.94 million. The company focuses on developing innovative therapies for cancer treatment. Patrys is committed to advancing its research and development efforts to address unmet medical needs in oncology.

PAB:ASXAUDAUUpdated September 11, 2026
Patrys Limited logo
Ticker
PAB:ASX
Asset type
Stock
Market cap
$15.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
ASX
Currency
AUD

Patrys Limited PAB:ASX stock context

This page tracks Patrys Limited's PAB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PAB:ASX. PAB:ASX is the stock-level entry point for investors researching Patrys Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Patrys Limited (Ticker: PAB) is a public company based in Australia with a market capitalization of approximately AUD 17.94 million. The company focuses on developing innovative therapies for cancer treatment. Patrys is committed to advancing its research and development efforts to address unmet medical needs in oncology.

Latest news from Patrys Limited

All Patrys Limited news →

Research Patrys Limited

Alternate listings